PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New class of compounds shrinks pancreatic cancer tumours and prevents regrowth

2015-06-25
(Press-News.org) Scientists from UCL (University College London) have designed a chemical compound that has reduced the growth of pancreatic cancer tumours by 80 percent in treated mice.

The compound, called MM41, was designed to block faulty genes. It appears to do this by targeting little knots in their DNA, called quadruplexes, which are very different from normal DNA and which are especially found in faulty genes.

The findings, published in Nature Scientific Reports, showed that MM41 had a strong inhibiting effect on two genes -- k-RAS and BCL-2 -- both of which are found in the majority of pancreatic cancers.

Funded by the UK charity, Pancreatic Cancer Research Fund, the UCL team, led by professor Stephen Neidle, conducted a small-scale trial, treating two groups of eight mice with pancreatic tumours with different doses of MM41 twice a week for 40 days (12 doses). A further control group received no treatment. The tumours in the group given the larger dose decreased by an average of 80 percent during the treatment period, and after 30 days, tumour regrowth stopped in all the mice. For two of the mice in this group, the tumour disappeared completely with no signs of regrowth after treatment ended for a further 239 days (the approximate equivalent to the rest of their natural life span).

Analysis of the mice tumours showed that the MM41 compound had been taken up into the nucleus of the cancer cells showing that it was able to effectively target the pancreatic cancer tumour.

The team also saw no significant side effects on the mice during the study: there was no damage to other tissue or organs, and none of the mice showed any significant weight loss.

Discussing the results, Neidle explained: "This research provides a potentially very powerful alternative approach to the way that conventional drugs tackle pancreatic cancer, by targeting a very specific area of the DNA of faulty genes. One of the genes that MM41 blocks -- the BCL-2 gene -- is involved in regulating apoptosis, the body's natural process which forces cells to die if they become too damaged or unhealthy to be repaired. BCL-2 is present in high amounts in many tumours and helps cancer cells to survive, but when the BCL-2 gene is blocked by MM41 in mice, the cancer cells succumb to apoptosis and die."

Neidle stressed that although these results are exciting, MM41 is not ideal for trialling in humans and further refinements are needed. "We are now working to optimise this class of compounds, but it's clearly worthy of further investigation for potential use in treating pancreatic cancer in people," he said.

Pancreatic cancer is the most lethal of any common cancer. Only three in every 100 people diagnosed will live for five years or more and this survival rate has barely improved in the last 40 years. The majority of patients are diagnosed too late for surgery -- currently the only potentially curative treatment -- and 80 per cent of those who have surgery will see the cancer return.

Maggie Blanks, Pancreatic Cancer Research Fund's CEO, said: "It's because of these bleak facts that our funding strategy focuses on finding and developing alternative, effective treatments for patients as well as finding a way to diagnose pancreatic cancer at an early stage. To find a potential new way to kill pancreatic cancer tumour cells is an exciting development."

INFORMATION:

The paper, A G-quadruplex-binding compound showing anti-tumour activity in an in vivo model for pancreatic cancer (doi:10.1038/srep11385) was published on 16 June and is available at http://www.nature.com/srep/2015/150616/srep11385/full/srep11385.html

Notes for editors:

About pancreatic cancer

Each year approximately 8,800 people in the UK are diagnosed with pancreatic cancer. It is an extremely difficult cancer to diagnose and treat because it is unusually aggressive; symptoms are often vague and generally appear at an advanced stage of the disease. With a five-year survival rate of 3 percent -- the lowest of all common cancers, it is the UK's 5th biggest cancer killer and yet receives less than 2 percent national research funding.

Pancreatic Cancer Research Fund (PRCF) http://www.pcrf.org.uk

PCRF is the only UK charity exclusively funding research into pancreatic cancer. Its mission is to defeat the disease by funding and promoting innovative, world-class research that will lead to the development of more effective detection, diagnosis and treatments.

The charity has so far funded 34 research projects worth £5.2M across universities in the UK and Ireland, with all projects funded entirely from public donations.

About UCL (University College London)

UCL was founded in 1826. We were the first English university established after Oxford and Cambridge, the first to open up university education to those previously excluded from it, and the first to provide systematic teaching of law, architecture and medicine. We are among the world's top universities, as reflected by performance in a range of international rankings and tables. UCL currently has over 35,000 students from 150 countries and over 11,000 staff. Our annual income is more than £1 billion.



ELSE PRESS RELEASES FROM THIS DATE:

Past water patterns drive present wading bird numbers

2015-06-25
Wading bird numbers in the Florida Everglades are driven by water patterns that play out over multiple years according to a new study by the U.S. Geological Survey and Florida Atlantic University. Previously, existing water conditions were seen as the primary driving factor affecting numbers of birds, but this research shows that the preceding years' water conditions and availability are equally important. "We've known for some time that changes in water levels trigger a significant response by wading birds in the Everglades," said James Beerens, the study's lead author ...

New breath test for pneumonia

New breath test for pneumonia
2015-06-25
Researchers from The University of Manchester are part of a team that has identified an important new approach to diagnose infections in critically ill patients rapidly and accurately. A study by colleagues in Salford and Manchester found that chemically analysing breath specimens from patients in intensive care can reveal bacterial infection in the lower respiratory tract of ventilated patients at risk of developing pneumonia. Although the work is in its early stages, the findings so far look very exciting and could potentially have a huge effect on clinical practice ...

Breakthrough graphene production could trigger revolution in artificial skin development

2015-06-25
A pioneering new technique to produce high-quality, low cost graphene could pave the way for the development of the first truly flexible 'electronic skin', that could be used in robots. Researchers from the University of Exeter have discovered an innovative new method to produce the wonder material Graphene significantly cheaper, and easier, than previously possible. The research team, led by Professor Monica Craciun, have used this new technique to create the first transparent and flexible touch-sensor that could enable the development of artificial skin for use in ...

Antarctic sponges: DNA barcoding discloses diversity

2015-06-25
Researchers at Ludwig-Maximilians-Universitaet (LMU) in Munich have used DNA barcoding to elucidate the diversity of the sponge fauna found in Antarctic waters. The data provide new insights into the evolution of this poorly characterized group. Sponges constitute an important component of marine ecosystems in the waters around Antarctica. As filter feeders that rely on food particles suspended in the water passing through complex networks of canals lined with flagellated cells, they provide protected niches for many other organisms. "In spite of their considerable ecological ...

Chimps are sensitive to what is right and wrong

2015-06-25
How a chimpanzee views a video of an infant chimp from another group being killed gives a sense of how human morality and social norms might have evolved. So says Claudia Rudolf von Rohr of the University of Zurich in Switzerland, lead author of a paper in Springer's journal Human Nature. It provides the first evidence that chimpanzees, like humans, are sensitive to the appropriateness of behaviors, especially those directed toward infants. It also shows that these primates might only take action when a member of their own group is being harmed. The researchers filmed ...

Johns Hopkins scientists restore normal function in heart muscle cells of diabetic rats

2015-06-25
Working with heart muscle cells from diabetic rats, scientists at Johns Hopkins have located what they say is the epicenter of mischief wreaked by too much blood sugar and used a sugar-gobbling enzyme to restore normal function in the glucose-damaged cells of animal heart muscles. In addition to much-needed insight into the process of diabetes-related heart damage, the study, described June 24 in the journal Diabetes, offers a clue to a possible treatment strategy for diabetic cardiomyopathy, a condition marked by progressive weakening of the heart muscle found in 60 ...

Infection preventionists may spend more time collecting data than protecting patients

2015-06-25
Nashville, Tenn., June 25, 2015--Collecting and reporting hospital infection data to federal health agencies takes more than 5 hours each day, at the expense of time needed to ensure that frontline healthcare personnel are adhering to basic infection prevention practices such as hand hygiene, according to a recent case study, to be presented on Saturday, June 27 at the 42nd Annual Conference of the Association for Professionals in Infection Control and Epidemiology (APIC). Infection preventionists (IPs) play a critical role in the effort to eliminate healthcare-associated ...

Pilot program in pediatric long-term care facility halves topical antibiotic use

2015-06-25
Nashville, Tenn., June 25 -- A pilot antibiotic stewardship program at a pediatric long-term care facility brought about a 59 percent decrease in use of a topical antibiotic and an 83 percent decrease in orders for antibiotics without proper documentation during a six-month period, according to a new study. When the infection prevention team at Elizabeth Seton Pediatric Center in Yonkers, N.Y. noticed that certain antibiotics were being prescribed for a prolonged period of time and for non-infection indications, they launched a trial program to make improvements in antibiotic ...

Researchers question what happens in the brain when we think

2015-06-25
New research from Lund University in Sweden questions the prevailing doctrine on how the brain absorbs and processes information. The idea that the brain has a mechanism to maintain activity at the lowest possible level is incorrect. What happens in the brain when we think and which components make up a thought? Researchers in Lund have taken a major step towards understanding this central issue. Since the 1980s, there has been a general consensus among neuroscientists that the brain has a system to maintain brain activity at the lowest possible level while retaining ...

Antarctic life -- highly diverse, unusually structured

2015-06-25
In a comprehensive assessment of Antarctic biodiversity, published in Nature this week, scientists have revealed the region is more diverse and biologically interesting than previously thought. The team of scientists, led by Monash University, along with colleagues from the British Antarctic Survey, University of Waikato in New Zealand, and Australian National University, looked at how recent investigations have revealed the continent and surrounding ocean is rich in species. They are also very highly diversified into a variety of distinct ecological regions that differ ...

LAST 30 PRESS RELEASES:

Norbert Holtkamp appointed director of Fermi National Accelerator Laboratory

New agentic AI platform accelerates advanced optics design

Biologists discover neurons use physical signals — not electricity — to stabilize communication

Researchers discover that a hormone can access the brain by hitchhiking

University of Oklahoma researcher awarded funding to pursue AI-powered material design

Exploring how the visual system recovers following injury

Support for parents with infants at pediatric check-ups leads to better reading and math skills in elementary school

Kids’ behavioral health is a growing share of family health costs

Day & night: Cancer disrupts the brain’s natural rhythm

COVID-19 vaccination significantly reduces risk to pregnant women and baby

The role of vaccination in maternal and perinatal outcomes associated with COVID-19 in pregnancy

Mayo Clinic smartwatch system helps parents shorten and defuse children's severe tantrums early

Behavioral health spending spikes to 40% of all children’s health expenditures, nearly doubling in a decade

Digital cognitive behavioral treatment for generalized anxiety disorder

Expenditures for pediatric behavioral health care over time and estimated family financial burden

Air conditioning in nursing homes and mortality during extreme heat

The Alps to lose a record number of glaciers in the next decade

What makes a good proton conductor?

New science reporting guide published for journalists in Bulgaria

New international study reveals major survival gaps among children with cancer

New science reporting guide published for journalists in Turkey

Scientists develop a smarter mRNA therapy that knows which cells to target

Neuroanatomy-informed brain–machine hybrid intelligence for robust acoustic target detection

Eight SwRI hydrogen projects funded by ENERGYWERX

The Lundquist Institute and its start-up company Vitalex Biosciences Announces Strategic Advancement of Second-Generation fungal Vaccine VXV-01 through Phase 1 Trials under $40 Million Competitive Con

Fine particles in pollution are associated with early signs of autoimmune disease

Review article | Towards a Global Ground-Based Earth Observatory (GGBEO): Leveraging existing systems and networks

Penn and UMich create world’s smallest programmable, autonomous robots

Cleveland researchers launch first major study to address ‘hidden performance killer’ in athletes

To connect across politics, try saying what you oppose

[Press-News.org] New class of compounds shrinks pancreatic cancer tumours and prevents regrowth